TIGLUTIK

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 11797-210
  • Package NDC 11797-210-01
  • Application number NDA209080
  • SPL ID 2ba33fab-05a6-42db-9b4a-277bb3a30f29
  • SPL set ID 20b7165a-eb4d-42a0-b2d8-16eff90a214e
  • UNII 7LJ087RS6F
  • RxCUI 2058147
  • RxCUI 2059266

What the source publishes

Labeler
Italfarmaco SPA
Active ingredients
Riluzole
Form
SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:11797-210_2ba33fab-05a6-42db-9b4a-277bb3a30f29
{
  "name": "TIGLUTIK",
  "splId": "2ba33fab-05a6-42db-9b4a-277bb3a30f29",
  "labels": [
    {
      "setId": "20b7165a-eb4d-42a0-b2d8-16eff90a214e",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20b7165a-eb4d-42a0-b2d8-16eff90a214e",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=20b7165a-eb4d-42a0-b2d8-16eff90a214e"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Italfarmaco SPA",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "2 BOTTLE, PLASTIC in 1 CARTON (11797-210-01)  / 300 mL in 1 BOTTLE, PLASTIC",
      "package_ndc": "11797-210-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20180921"
    }
  ],
  "productId": "11797-210_2ba33fab-05a6-42db-9b4a-277bb3a30f29",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "11797-210",
  "deaSchedule": null,
  "genericName": "Riluzole",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RILUZOLE",
      "strength": "50 mg/10mL"
    }
  ],
  "applicationNumber": "NDA209080",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20180921",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175740",
      "M0483511"
    ],
    "unii": [
      "7LJ087RS6F"
    ],
    "rxcui": [
      "2058147",
      "2059266"
    ],
    "spl_set_id": [
      "20b7165a-eb4d-42a0-b2d8-16eff90a214e"
    ],
    "pharm_class_cs": [
      "Benzothiazoles [CS]"
    ],
    "pharm_class_epc": [
      "Benzothiazole [EPC]"
    ],
    "manufacturer_name": [
      "Italfarmaco SPA"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:11797-210_2ba33fab-05a6-42db-9b4a-277bb3a30f29"